- Home
- SVAC vs CLPT Comparison
SVAC vs CLPT Comparison
Compare SVAC & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$12.28
Company Overview
Basic Information| Metric | SVAC | CLPT |
|---|---|---|
| Founded | 2025 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 353.5M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | SVAC | CLPT |
|---|---|---|
| Price | $10.50 | $12.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 199.0K | ★ 411.6K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $45.67 |
| Revenue Next Year | N/A | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $10.06 | $8.27 |
| 52 Week High | $12.00 | $30.10 |
Technical Indicators
Market Signals| Indicator | SVAC | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 60.76 | 60.24 |
| Support Level | $10.27 | $10.05 |
| Resistance Level | $10.55 | $15.09 |
| Average True Range (ATR) | 0.11 | 0.81 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 73.36 | 73.22 |
Price Performance
Historical Comparison SVAC
CLPT
About SVAC Spring Valley Acquisition Corp. III Class A Ordinary Shares
Spring Valley Acquisition Corp III is a blank check company.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.